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The activities and properties of the enzymes involved 
in t he formation and degradation of pyroglutamic acid 
(2-pyrroIidone-5-carboxylic acid, 5-oxoproline) in guinea 
pig epidermis have been studied. The enzyme pattern 
W"as characterized by an extremely high activity of y-
glutamyl cyc1otransferase. The epidermal extracts po-
sessed a m easurable, but rather low activity of pyroglu-
taxnate hydrolase. It is suggested that the only major 
pathway by which pyroglutamate may be fOl'med in 
epidermal tissue is from L-glutamate by a 2-step reac-
tion, the first involving the formation of a y-glutamyl 
peptide by the action of y-glutamyl-cysteine synthetase, 
and the second cyc1ization of the y-glutamyl moiety by 
the action of y-glutamyl cyc1otransferase. Abundant sub-
strate supply, the extrem ely high cyclotransferase activ-
ity and the rather low capacity to degrade pYl'ogluta-
mate may be the factors responsible for the accumula-
tion of this compound in epidermal tissue. A relatively 
10"W' content of reduced glutathione may also be a con-
tributing factor. 
Pyroglutamic acid (2-PYIT0Iidone-5-carboxylic acid, 5-oxo-
proline) has received growing attention during the last years, 
owing to its suggested participation in the gamma-glu tamyl 
cycle [1], and to the recent discovery of a new inborn error of 
metabolism characterized by the excretion of large amounts of 
pyroglutamic acid in the urine [2,3]. The presence of high 
concentrations of pyroglutamic acid in mammalian epidermis 
was first demonstrated by Pascher in 1956 [4], and later con-
firmed by several investigators. In a previous report from this 
laboratory we found that pYl"Oglutamic acid constituted approx-
imately l.6% of the fi'esh tissue weight of the horny layer from 
human epidermis, and we were a ble to show that aU the 
epid ermal p.Y'l'oglutamate was present as the L-isomer [5]. 
Traces of pyroglutamate can be demonstrated in most organs, 
but so far the epidermis apperu's to bel the only tissue where 
pyroglutamate accumulates in significant amounts. 
In general, pyroglutamic acid may be formed in several ways 
[see review by Orlowski and Meister [6]]. The compound may 
originate from y-glutamyl peptides by the action of the enzyme 
y-glutamyl cyclotransferase. y-glutamyl peptides not suscepti-
ble to the action of the cyclo transferase may be transformed to 
active substrates by the prior action of another enzyme, y-
glutamyl transpeptidase . Direct cyclization of L-glutamate or 
L-glutamine to pyroglutamate is another possible route of for-
mation [6-9], and it may also be produced fTom pept ides 
containing an N-termina l pyroglutamate residue [6]. The only 
known degradative pathway for pyroglutamate is its conversion 
to glu tamic acid, involving ring opening by the ATP-dependen t 
pyroglutamate hydrolase (5-oxoprolinase). 
Little information exists regarding the processes leading to 
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the striking epidermal accumulation of pYl'oglutamate. Direct 
cycJization of L-glutamate and L-glu tamine in skin has been 
reported [8,9], but the quanti tative role of these reactions as 
compru'ed to other routes of formation is not known. 
The purpose of the present investigation has been to obtain 
new information on the metabolism of pYl'oglu tamate in epi-
dermis. Guinea pigs were selected as experimental animals, as 
their ep idermis is particulru'ly rich in pyroglu tamate [10). T he 
present r esul ts show that the high amoun t of pYl'oglu tamate in 
skin is likely to originate via the formation of y-glutamyl pep-
tides and the subsequent action of the enzyme y-glu tamyl 
cycJotransferase on these peptides. 
MATERIALS AND METHODS 
Cheinicals 
I.IC (U}-L-pyroglu ta mic ac id, I.IC (U}-L-glu tamic acid and I.IC (U}-L-
gluta mine were obtained frol11 NEN Chemicals, D reieichenha in, West 
Germany. Thin-layer chromatography demonstrat.ed that the rad iola-
beled glu ta mic ac id a nd glu tamine conta ined significant amounts of 
radioactive pyroglu ta mate. Purifica tion was performed by ion exchange 
chromatography 011 a small column of Dowex 50 W (H+-form). T he 
radjoactive glu tamate and glu tamine will be adsorbed to the resin, 
while the pyrogluta mate may be removed by washing the column with 
wate r. The rad ioactive glu tamate a nd glu tamine were elu ted from the 
column with strong hydrochloric ac id which subsequently was removed 
by evaporation on a rota vapor. T esting of t he purified mai.erial showed 
negligible amoun ts of radioactive pyroglu tamate. y-glu t.amyl peptides 
except y-L-glutamyl-L-cysteine were purchased from CalBiochem, La 
Jolla , California. The latte r peptide was synthesized from oxid ized 
glu ta thione by the method of Stl'llmeyer a nd Bloch [II]. L-pyroglu-
i.am ic acid was obtained from Fluka AG, Buchs, Switze rla nd , and L-
glu tamic ac id dehydrogenase was the product of S igma Chemical 
Company, St. Louis, USA. Labeled and unla beled L-pyroglu tamyl 
amide were prepared by the method of Angier et al. [ J21 using L-
glu tamate and I.IC (U} -L-gluta mate respectively as sta rting ma teria ls. 
Preparation of Epidermal Extracts 
Adult ma le guinea pigs were sacrificed by a blow to the head, and 
the skin of the righ t fla nk was shaved a nd removed. T he epide rmis was 
separated from the dermis by t.he st.retch method as described by 
Rosett et al [13]. A specia l apparatus was constructed in order t.o exert 
maxima l tension on the skin while scra ping off the epidermis. 0.5- 1.0 
gm of epidermal tissue was collected from each a ni mal and immed iately 
suspended in 10 ml of ice-cold sucrose (250 mmol/l conta ining 10 mmol/ 
I T ris-H CI (pH 7.8) a nd 1 mmol/I EDTA). The t issue was treated for 
15 seconds wi th a n Ultra-Turrax apparatus in the cold a nd then severa l 
times in a Potter Elvehjem homogenizer using a Teflon pestle. The 
homogenates were centrifuged at 200 xg at 4°C for 10 min to remove 
t he debris. The particle-free fraction was obtained by centrifugat ion at. 
48000 xg in a refrigerated cent rifuge for 30 min. The reSUlting pellet 
was resuspended in buffered sucrose solu t ion a nd dilu t.ed to its origina l 
volume. The protein content of the superna tant fract.ion ranged from 
2.0-3.5 mg/ml. All extl'llcts were kepI. al -20°C foJ' a maximum of 2 
weeks before being assayed. No deterioration of the enzymes under 
study could be demonstrated during this t ime. Endogenous p'y roglut a-
mate a nd other int erfering low molecular we ight substances were 
removed Wior to the assays by gel fil tration of the extracts on small 
columns (6 ml) of Sephadex G 25 (coarse grade). T his procedure di luted 
the samples by a facto r of a bou t 1.7. 
Detenninatioll of Py rogllltamate 
Proteins were precipitated with perchlor ic ac id (final concentration 
0.67 mol/ I) and removed by centrifugat.ion. Aft.er neut ralization of t.he 
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supernatant with KO H and remova l of' the insolu ble potassiu m per-
chlorate, an a liquot was applied on the top of a small column (2 m!) of 
Dowex 50 W (H+ -fo rm). T he column was washed with water (6 ml) . 
The eluate conta ined the pyroglutamate, whilst the am ino acids were 
reta ined on the colu mn. Sod ium hydrox ide was added to the eluate 
(final concentration 0.5 mol/ I), and the mixture was pl aced in a boiling 
water bath for 60 min . T his converted all the pyroglu tamate to glu ta-
ma te. After neutra lization with HCI, the glutamate content of the 
mi xture was dete rmined enzymatically by means of' L-glutamate de-
hydrogenase [.l 4l 
En zyme Assays 
PyrogLutam.ate hydroLase (5 -oxo-proLinase): This was a sayed by a 
mod ifi cation [151 of the original method of van del' Welt, Orlowski , and 
Meister [Hi"! us ing rad iolabeled pyroglutamate as substrate (200 Ilmol/ 
I). Ge lfi ltered pa rt icle-free extracts were used as enzyme source (200 
I.!I in a total volume of 1 mI) . 
y- Glulam.yl cyclolran.sferase: This activity was determined by mea-
suring the rate of production of pyroglu tamate from y-glu tamyl pep-
tides. T he assay was performed on gelfil te red particle- free extracts. 
T he incuba tion mixture (final volume 150 f.L1) conta ined Tris-HCI (0.1 
mol/I, pH 8.2), the y-glu tamyl peptide (60 mmol/I) and 5 f.L1 of tissue 
extract. D ifferent y-glu tamyl peptides were used as substra te. The 
react ion was slopped by adding percloric acid , and the pyroglutamate 
content of the reaction mixtw'e was dete rmined as described above. 
Di,.ect enzym.atic c:yclizalion of L -g lutamine: This was measured as 
descri bed fo r y-glu tamyl cyclotransf'erase except that L-glu ta mine was 
used as substrate instead of a y-glutamyl peptide and the volume of 
tissue extract increased to 50 ,ul. Spontaneous nonenzymatic cyclization 
was also determined by incubation of L-glut.amine in phosphate- buffer 
(pH 7.0) at 37°C followed by analys is of the formed pyroglutamate as 
desc ri bed above. 
En zym atic fo ,.mation of py,.oglllt cunate ("0111. L -gllltam.ate: T his was 
dete rmi ned in a reaction mixture (fin al volu me 1 ml ) conta ining Tris-
buffer (0.1 mol/ I, pH 7.8), Mg++ (20 mmol/ I), "C(U)-L-glu tamate (4 
mmol/ I) and 400 f.L I of the gelfil tered epidermal extract. In some 
experi me nts pyruvate a lone or in comb ination with ATP was added to 
the reaction mixture (see references 7 and 9). In other experiments <y-
L-aminobutyrate or L-cyste ine with or wi thout ATP were added. The 
reaction was stopped by plac ing the mixtures f'or 1 min in a boiling 
water batli . Afte r remov ing the precipi tated prote ins by centrifugation, 
an aliquol was applied to the lop of a small column of Dowex 50 W 
or -fo rm) and elu ted with water «() mI) . T he eluate conta ining the 
formed pyroglutamale was evaporated to dryness. T he residue was 
dissolved in 2 N HCI and placed in a boiling water bath for ()O min, 
thereby co nverti ng the elu ted pyroglu tamate to glu tamate. The acidic 
solvent was removed and the residue was dissolved in distilled waLe I'. 
T he solu tion was applied to the same Dowex 50 W column, and the 
rad iolabelecl glu tama te was elu ted with HCI ( LO ml of 3 N) and subse-
quently counted in a liquid scin tillation counter. 
y-Gll/tamyl tran.sp eptidase: T his was determined using y-L-gluta-
myl-4 -ni troanilide as substrate according to the recommenda tion of the 
Scandinavian Commitlee on Enzymes [1 7). Parls 0 (' the lotal epidermal 
homogenate was mixed with 1 pa rt 10% sodium deoxycholate in water 
and treated several t imes in a Potter Elvehjem homogenizer and then 
left at room temperature for 4 hr. After centrifugation a t 48000 g for 30 
min, the clear supernatant was used as enzyme source. 
L-py ,.ogllltamyl pep tidase: Activity was determined by measuring 
the produ ction of free radiolabeled pyroglutamate from radioactive 
pyroglu tamyl amide. T he incubation mixture (fin al volume 1 ml) con· 
ta ined T ris-buffe r (0.06 mol/I, pH 7.6), radiolabeled pyroglu tamyl 
amide (1 mmol/I) and 500 f.L1 of the gelfil te red epidermal extract. T he 
reaction was stopped by add it ion of perchloric ac id (which subsequently 
was removed as des ~r i bed above). Free pyroglutamate in the superna-
tant was isolated by adsorption onto a column of Dowex 1 (CI- -form) . 
The pyroglu tamate was elu ted from the column wi th 3 N HCI and an 
aliquot coun ted in the liquid scin ti llation spectrometer. 
Determ ination o( Nonprotein Sul(hydryl Con.tent 
Deproteinized epide rmal ex tracts were prepared as described above. 
and the sulfhydryl content was determined by reaction with EUmans 
reagent (5.5' -d ithiobis- (2- nitro benzoic ac id)) [18]. 
Proteins: T hese were determined as described by Lowry et al [19]. 
RESULTS 
Pyroglutal11ate Content 
T h e m ea n PYToglu tam ate co nte nt of th e guinea pig epidermal 
extracts was found to b e 2.83 f.Lmol es/m g soluble pro t e in (range 
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2.19-3.02), corresponding to a bou t 100 fLm oles/gm wet t issue 
weigh t . These values al'e som ewhat lower t h a n t hose r ep or ted 
by o the r in vestigators [10]. 
Degradation of Pyroglutal11ate 
The pa r t icle-free fraction of t h e epide rmal extracts possessed 
a [ow, but distinc t activity of pyroglu tam ate h ydrolase Cr a bl e 
I) . The r esults fi'om the kine tic experime nts produced a str a igh t 
line on a Lineweave r-Burke plo t, giving a n a ppare nt Mich aelis 
constant for pyroglutamate of 2.7 . 10- 0 m ol/I. The enzy m e was 
str o ngly inhibi ted by Ellma ns reagen t at a co ncentrat ion of 10-" 
m ol/ I. This inh ibition cou ld be com pletely r eversed by dithio-
tlue itol, indicating the impo rtance of S H -groups for e nzym e 
activ ity. 
Formation of Pyrogiutamate 
The epide rmaJ extracts s howed ver y high cyclotr a nsferase 
activity towa rds a number of y-glutam y l p ep tides (Ta ble II) . 
B y fa r th e hi gh est activity was obta in ed wi t h y-L-glu tam y l-
L -gluta min e as subs tra t e. Ther e was no de tec table a c tivity 
towa rds glutathione_ All t he cyclot l'a ns fe rase act ivi ty was found 
in t h e p articl e- I-i'ee fraction of the h omogena te. Kine tic expe ri-
m en ts with y-L -glu tamy l-L-glut3l nine a nd y-L-gluta myl-L-glu-
tam a te produced stra igh t lines on a Lineweaver-Burke plot 
g iv ing a n a ppa rent K", for bo t h subs tra tes of a pproximately 3 
. 10- 2 m o l/I. N o cofacto rs wer e required. 
Direct enzym a tic cycliza tion of L-glu tamine was not d e tect-
a bl e, even wh en th e sens itivity of the assay was enha nced by 
t he use of ra d iola be led compounds. Addi t ion of M g++ or K + 
h a d no e ffect, nor was ther e any effect of incr eas ing the pH to 
9.0. The spontan eous cyclization of glu tamine under t h e con -
dit ions described a bove fo ll owed a n exponentia l curve wi t h a 
rate cons tant of 2.1 - 10-" lu·- '. 
No co nvers ion of L-gluta m ate to pyroglu tam a te took place 
in the a bsen ce of added cofactors (Ta ble 111) . Addi t ion of 
pyruvate alone or in combina tion with ATP ha d no e ffect (see 
r e fe ren ce 9) . However , when L-cyste ine a nd ATP wer e a dded , 
forma tion of py rogluta m ate could r eadiJy be demonstrated. 
S ubstit u t ing cx-L-amino butyra t e for L-cyst e ine resul ted in in-
c reased production of py roglu ta ma te . The forma t ion of py ro-
glutam ate incr eased linearly wi th t ime a nd amoun t of enzym e 
added . S ma ll a moun ts of pyroglu tam a te were a lso produced 
wh en L-cys te ine was subs titu ted with certa in other a mino acids, 
e.g. L-alanine a nd L-tlu-eonine, while ot h e rs , e .g. L-methionine 
a nd L-glu tamine h a d no effec t . No form a tio n of pYTogluta m ate 
took place n e ither with L -cysteine nor with cx-L-a minobutyr a t e 
T A B L E 1. Enzym.e activities in guinea. pig epiciermi:;" 
Pyroglutamate hydrolase 
y-g\u tamyl cyc\otrans[erase 
E nzymali . cyclization of L-glu tamate 
E nzymatic cyclization of L-glutam ine 
y-glu tamyl t ranspept idase 
Pyroglutamyl peptidase 
0.16 
2720 
1.56 
N. D." 
2.5 
0.75 
(0.09-0. 19) 
(2150- 3360) 
(l .42- 1.84) 
(1.8-2.9) 
(0.53-0.93) 
" Mean and range of results from 10 animals. Enzyme activities are 
expressed as nanomoles of substrate converted/ min / mg protein. 
/, N.D. = not detectable. 
T AB L E II. S ubstrate specificity of y-glll tam.y l cyclot,.wv>!erase (rom 
guin ea pig epidermis 
Substrate 
y-L-glu tamyl-L-glutamine 
y-L-glu tamyl-L-alanine 
y-L-glu tamyl-L-glu tamate 
y-L-glu tamyl-L-glycine 
y-L-glu ta myl-L-valine 
y-L-glu tamyl-L-cysteine 
Glu tathione, reduced form 
Glutathione, oxidized form 
Relative 
activity 
100 
17.0 
6.5 
2.6 
0.4 
5.8 
N .D . 
N.D. 
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TABLE III. En zymatic formation of pyroglutamate from L· 
g lutamate: Cofactor requiremen.t." 
SysLem 
L N o additions 
2. Add A TP + pyruvate 
3. Add L-cysteine 
4. Add A TP + L-cysteine 
5 . Add A 1'1' + a-L-aminobu tyrate 
6. Add AT1' + L-cysteine + GSH (20 mmol/I) 
7 . Add ATP + L-cysteine + dithiothreito l (20 
mmol/I) 
8. Add ATP + L-cysteine + EDTA (20 mmol/ I) 
HelaLive 
activity 
N.D. 
N.D. 
N.D. 
100 
] 33 
10 
75 
N.D. 
"The concen tration of AT1', when added, was 2.5 mmol/l. The 
concen tration of pyruvate, L-cysteine a nd a-L-aminobuty rate, when 
added, were 20 mmol/1. Condi tions otherwise as stated in the text. 
if ATP were omitted. The reaction also had an a bsolu te require-
ment fO!' Mg++ and was completely inhibited when EDTA was 
added in excess. The reaction was inhibited more than 90% by 
the addition of 20 mmoljl of reduced glutathione (GSH), while 
dithiothreitol had only minor effects. y-glutamyl-cysteine also 
inhibited the reaction, but considerably less than glutathione. 
After centrifugation of the epidermal extracts, only the super-
natant fraction had the a bili ty to catalyse the cyclization of L-
glutamate. 
Kinetic experiments using glutamate and cx-aminobutyrate as 
variable substrates gave an apparant K", for glutamate of 2 
mmoljl and for a-aminobutyrate of 1.4 mmol/1. 
The activities of y-glu tamyl trapspeptidase determined in th e 
deoxycholate-treated epidermal homogenates are shown in 
Table 1. In contrast to t he high cyclotransferase activity, t he 
epidermis demonstrated only moderate activities of y-glutamyl 
transpeptidase. 
T a ble I also demonstrates the presence of appreciable activity 
of pyroglutamyl pept idase in t he particle-free fraction of t he 
t issue extracts. The reaction was susceptible to product inhibi-
tion by pyrogluta mate and exhibi ted sligh tly nonlinear time 
c u rve. For the same reason false low activities were recorded 
when crude, not gelfiltered epidermal extracts were used. Ki-
netic experiments gave an apparent K", fo), py)'oglutamyl amide 
of 0.3 mmol/1. The inhibition by pyroglutamate was shown to 
be the competitive type (Figure). 
Determination of the nonprotein sulfhydryl conten t of ep i-
dermal extracts from 3 animals gave a mean value of 1.09 j.Lmol/ 
g wet tissue weight (range 0.99-1.17) . 
DISCUSSION 
The enzyme pattern of guinea pig epidermis is characterized 
by an exceptional high activity of y-glutamyl cyclotransferase. 
Comparative studies in kidney and liver cells (results not 
s hown) showed cyclotransferase activit ies in these t issues of 
less than one-ten th of that recorded in t he epidermis. Our 
studies show that a number of y-glutamyl peptides may function 
as substrate for the enzyme. 
In contrast to the results obtained by Wolfersberg and Ta-
bachnick [8) we were una ble to demonstrate any enzymatic 
formation of pyroglutamate from L-glutamate when the latter 
was incubated with the epidermal extracts alone. Niwaguchi , 
Motohashi, and Strecker [7] have demonstrated the conversion 
of L-glutamate to pyroglutamate by the nuclear fraction of rat 
liver homogenates when incubated in the presence of ATP and 
some carbohydrate substra te, e.g., pyruvate. A similar activity 
h as later been reported to be present also in the mitochondrial/ 
nuclear fraction of rat epidermis [9]. We were unable to confirm 
th ese results in the present study. However, provided L-cysteine 
o r a -L-aminobutyrate was supplied in addition to ATP, cycli-
zation of L-glutamate was shown to take place at a considerable 
rate. Both of the added amino acids are known to be excellent 
s ubstrates for the enzyme y-glutamyl-cysteine synthetase [20]. 
T his strongly suggests that the cyclization of L-glutamate to 
30 
l/V 
10 
2 4 
liS 
FIG. Inhibition of pyroglll tamyl pept idase by pyroglutamate. Dou-
ble reciprocal plot. Open sym.bols: wit hout added pyroglll tamate. 
Closed symbols: after add it ion of pyroglu tamat.e ]0 mmol/1. Condi-
t ions otherwise as stated in the text. Abscissa: (010101/ 1) - '. Ordinate: 
(n111ol/l) - '. 
pyroglutamate proceeds via a 2-step reaction, t he first involving 
t he formation of a y-glutamyl peptide catalyzed by y-glu tamyl-
cysteine synthetase: 
ATP ADP 
L-G LU + L-AA --~--===---~) y-L-GLU-L-AA 
Mg++ 
(1) 
The second step involves cyclization of the y-glutamyl moiety 
by the action of y-glutamyl cyclotransferase: 
y-L-GLU-L-AA--~) L-PYROGLU + L-AA (2) 
Orlowski and Meister [20] have shown that a number of amino 
acids may function as acceptor of the y-glutamyl moiety in the 
reaction catalyzed by y-glutamyl-cysteine synthetase, but by 
far t he highest activity was obtained with L-cysteine a nd a-L-
aminobu tyrate. However, ou)' studies showed that also certain 
other amino acids, e.g. alanine and th.reonine, were able to 
promote the cyclization of glutamate by epidermal homoge-
nates. The first reaction step is energy consuming and requires 
ATP, and th e enzyme has been shown to have an absolute 
requirement for magnesium [20]. In accordance with this we 
found that no pyrogiutamate production took place if ATP was 
omi tted or if Mg++ was removed by the addition of excess 
EDTA. Reduced glutathione is known to be an efficient inhib-
itor of y-glu tamyl-cysteine synthetase activity [21), and in 
agreement with this we found that pyroglu tamate production 
was strongly inhibited by GSH, while another sylfhydryl re-
agent, dithiothreitol, had mu ch less effect. 
No accumulation of y-glu t.amyl peptides OCClU'red during the 
cyclization of glu tamate. This was as expected in view of the 
very high cyclotransferase activity of t he epidermal extracts. In 
accordance with previous reports [22] our tudies howed that 
a number of y-glu tamyl peptides may funct ion as substrate for 
the cyclotransferase (Table II). As a consequence, the y-gluta-
my I peptide formed in the first reaction (reaction 1 above) wil l 
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immediately be acted upo n by the abundan t cyclotransferase 
and th ereby converted to pyroglu tamate a n d a free amino acid . 
In a previous report from t h is la boratory we described t h e 
formation of pyroglu tamate from L-glutam ate in h emolysates 
from human eryth rocytes, which con tain much less cyclotrans -
ferase activity [23]. In this instance accumulation of y-glu tam yl 
peptides was readily dem onstrated . 
T h e activity of y-glu tamy l transpeptidase is relative ly low in 
t h e epiderm is. However, as t h e peptides form ed by t h e action 
of y-glu tamyl-cysteine synth etase are sh own to be directly 
convertible by t h e cyclotransferase, t he form ation of pyroglu -
tamate seems to be independen t of a prior transpeptidation 
step. 
T h e present studies h ave sh own a substantial activity of 
pyroglutamyl peptidase to be present in epidermal t issue. How-
ever, under t h e condit ions prevailing in epid ermis wit h the high 
co ncentration of pyroglu tamate, on e would expect t his enzym e 
to be a lmost completely inhibited. A lso taking in to account t h at 
this route of pyroglutamate fo rmation would require t h e pr ior 
formation of pyroglu tam y l peptides, t h e pyroglu tamy l pepti-
dase seems to be of little or n o importan ce in th e epiderma l 
production of pyroglu tam ate. 
Also in con trast to Wolfersberger a nd Tabachnick [8] we 
were unable to d em onstrate any enzymatic cyclization of L -
glu tamine to pyroglu tamate, and furthermor e glutamine did 
not substitute for glu tam ate in t h e y-glutamyl-cysteine synt h e-
tase catalyzed reactio n. Even if a su bstan tial spon taneous cy-
clizatio n of L-glutamine could be d em onstr ated , t his reaction is 
not fast enough to account fo r t h e high pyroglu tam ate con tent 
of epidermal tissue. 
It appears t herefore t h at t h e only m ajor path way by which 
pyroglutamate may be formed in epiderma l t issue is fTom L -
glutamate by a 2-step reaction catalyzed by t h e successive 
action of y-glu ta myl-cysteine syn t hetase a nd y-glu tamyl cyclo-
transferase. Ou!" studies furth ermore dem onstrate t hat epider -
mal t issue possesses a measureable, bu t rath er low a bili ty to 
degrade p.yroglu tam ate to glu tam ate. It must be born in mind 
t hat t h e in vivo activit ies of t h e enzymes discussed a bove m ay 
differ fro m those r ecord ed under saturating condi tions in vitro. 
However, abundan t substrate supp ly a nd th e extrem ely high 
cyclotransferase activity, combined wit h a low capacity to d e-
grade pyroglutam ate, m ay expla in t he accumulation of t his 
compound in epidermal tissue. Another con tribu t ing factor m ay 
also be t h e re latively low concentration of GSH in epiderma l 
t issue with less inhibi t io n of th e y-glutam ylcysteine synthetase 
reaction . 
T he skillful technical assistance of Mrs. Siri Tverdal is gra tefully 
acknowledged. I am indebted to Dr. E. Je llum for helpful d iscussions. 
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